Ruibin Wang1, Sabina A Haberlen1, Frank J Palella2, Michael J Mugavero3, Joseph B Margolick4, Bernard J C Macatangay5, Otoniel Martínez-Maza6, Lisa P Jacobson1, Alison G Abraham7. 1. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. 2. Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, Illinois. 3. Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama. 4. Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. 5. Department of Infectious Diseases and Microbiology, University of Pittsburgh, Pittsburgh, Pennsylvania. 6. Department of Obstetrics & Gynecology, Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine at UCLA, Los Angeles, California. 7. Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Abstract
OBJECTIVE: Ongoing HIV replication while receiving combination antiretroviral therapy (cART) may reduce survival. Viremia copy-years (VCY) has shown improved mortality risk prediction over single time-point viral load measures. However, the timing of a patient's viral load history most associated with later mortality has not been studied. Here we determined the optimal duration and temporality of viral load history for predicting mortality. DESIGN: Survival analysis among HIV-positive men who initiated cART in the Multicenter AIDS Cohort Study (1995-2015). METHODS: VCY measures were derived from area-under-the-viral load-curve. The overall VCY based upon the complete post-cART viral load history was compared with 20 VCYs derived from viral loads assessed during different shorter time periods (the most recent 1-10 years and initial 1-10 years following cART initiation) for associations with mortality. RESULTS: Each 10-fold increase in VCYs based on the most recent 3-8 years was significantly associated with 23-26% decrease in survival times, a magnitude of effect greater than that of the most recent viral load (16%). These associations were independent of CD4 cell count and single time-point viral loads. In addition, the degree of pre-cART immunodeficiency did not affect the mortality prognostic value of VCY based on viral loads in the most recent 3 years. Conversely, the overall VCY and VCYs based on viral loads immediately following cART initiation were not independent predictors of mortality. CONCLUSION: Among cART-treated men, VCY based upon viral loads in the recent 3 years (six viral loads) has a mortality prognostic value greater than that of the overall VCY and single time-point viral loads, making the former a more feasible measure for use.
OBJECTIVE: Ongoing HIV replication while receiving combination antiretroviral therapy (cART) may reduce survival. Viremia copy-years (VCY) has shown improved mortality risk prediction over single time-point viral load measures. However, the timing of a patient's viral load history most associated with later mortality has not been studied. Here we determined the optimal duration and temporality of viral load history for predicting mortality. DESIGN: Survival analysis among HIV-positive men who initiated cART in the Multicenter AIDS Cohort Study (1995-2015). METHODS: VCY measures were derived from area-under-the-viral load-curve. The overall VCY based upon the complete post-cART viral load history was compared with 20 VCYs derived from viral loads assessed during different shorter time periods (the most recent 1-10 years and initial 1-10 years following cART initiation) for associations with mortality. RESULTS: Each 10-fold increase in VCYs based on the most recent 3-8 years was significantly associated with 23-26% decrease in survival times, a magnitude of effect greater than that of the most recent viral load (16%). These associations were independent of CD4 cell count and single time-point viral loads. In addition, the degree of pre-cART immunodeficiency did not affect the mortality prognostic value of VCY based on viral loads in the most recent 3 years. Conversely, the overall VCY and VCYs based on viral loads immediately following cART initiation were not independent predictors of mortality. CONCLUSION: Among cART-treated men, VCY based upon viral loads in the recent 3 years (six viral loads) has a mortality prognostic value greater than that of the overall VCY and single time-point viral loads, making the former a more feasible measure for use.
Authors: Yunan Xu; Xinguang Chen; Akemi Wijayabahu; Zhi Zhou; Bin Yu; Emma C Spencer; Robert L Cook Journal: Curr HIV Res Date: 2020 Impact factor: 1.581
Authors: Kristine M Erlandson; Long Zhang; Derek K Ng; Keri N Althoff; Frank J Palella; Lawrence A Kingsley; Lisa P Jacobson; Joseph B Margolick; Jordan E Lake; Todd T Brown Journal: J Acquir Immune Defic Syndr Date: 2019-08-01 Impact factor: 3.731
Authors: Mary E Sehl; Elizabeth Crabb Breen; Roger Shih; Larry Chen; Ruibin Wang; Steve Horvath; Jay H Bream; Priya Duggal; Jeremy Martinson; Steven M Wolinsky; Otoniel Martinez-Maza; Christina M Ramirez; Beth D Jamieson Journal: Front Genet Date: 2022-02-28 Impact factor: 4.772
Authors: Lucia Taramasso; Federica Bozzano; Anna Casabianca; Chiara Orlandi; Francesca Bovis; Sara Mora; Mauro Giacomini; Lorenzo Moretta; Mauro Magnani; Antonio Di Biagio; Andrea De Maria Journal: Front Immunol Date: 2022-04-26 Impact factor: 8.786
Authors: Lauren F Collins; Anandi N Sheth; C Christina Mehta; Susanna Naggie; Elizabeth T Golub; Kathryn Anastos; Audrey L French; Seble Kassaye; Tonya N Taylor; Margaret A Fischl; Adaora A Adimora; Mirjam-Colette Kempf; Frank J Palella; Phyllis C Tien; Ighovwerha Ofotokun Journal: Clin Infect Dis Date: 2021-10-05 Impact factor: 9.079
Authors: Aaloke Mody; Ingrid Eshun-Wilson; Kombatende Sikombe; Sheree R Schwartz; Laura K Beres; Sandra Simbeza; Njekwa Mukamba; Paul Somwe; Carolyn Bolton-Moore; Nancy Padian; Charles B Holmes; Izukanji Sikazwe; Elvin H Geng Journal: PLoS Med Date: 2019-10-29 Impact factor: 11.069
Authors: Giovanni Sarteschi; Antonio Di Biagio; Emanuele Focà; Lucia Taramasso; Francesca Bovis; Anna Celotti; Michele Mirabella; Laura Magnasco; Sara Mora; Mauro Giacomini; Matteo Bassetti Journal: PLoS One Date: 2020-10-15 Impact factor: 3.240